PATENT CLAIM ANALYSIS

Application Number: 16123886
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "601000"]

Abstract:
The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I: as defined in the specification. The invention is also directed to compositions containing and uses of the compounds of formula I.

Claim (Index 15):
The method according to  claim 5 , or a pharmaceutically acceptable salt thereof, wherein ring \u201cB\u201d is (C 4 -C 10 )cycloalkyl; n is zero or one; and wherein R 2  is hydrogen, halogen, hydroxyl, \u2014CF 3 , \u2014CN, \u2014(C\u2550O)R 8 , \u2014O\u2014(C\u2550O)\u2014R 8 , \u2014(NR 8 )\u2014(C\u2550O)\u2014R 8 , \u2014(C\u2550O)\u2014OR 8 , \u2014(C\u2550O)\u2014N(R 8 ) 2 , \u2014OR 8 , \u2014O\u2014(C\u2550O)\u2014OR 8 , \u2014O\u2014(C\u2550O)\u2014N(R 8 ) 2 , \u2014NO 2 , \u2014N(R 8 ) 2 , \u2014(NR 8 )\u2014SO 2 \u2014R 8 , \u2014S(O) w R 8 , \u2014SO 2 \u2014N(R 8 ) 2 , and (C 1 -C 6 )alkyl; wherein said (C 1 -C 6 )alkyl is optionally substituted with one, two, three or four R 9 .

Metadata:
- Claim Count in Document: 84.0
- Percentile: 97.0
- Lexical Diversity: 1.63333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13596492', '12823224', '15318207', '14549848', '12525095']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7773521755759918
- 35 USC 102 Novelty (BERT): 0.5711815874501369
- Combined Prediction Score: 0.7567351167634063
- Mean Citation Score: 360.57902
- Max Citation Score: 475.453
- Similarity Product: 336.38432037419085

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test